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Abstract
Ixodid ticks are notorious blood-sucking ectoparasites and are completely dependent on blood-meals from hosts. In
addition to the direct severe effects on health and productivity, ixodid ticks transmit various deadly diseases to humans and
animals. Unlike rapidly feeding vessel-feeder hematophagous insects, the hard ticks feed on hosts for a long time (5210
days or more), making a large blood pool beneath the skin. Tick’s salivary glands produce a vast array of bio-molecules that
modulate their complex and persistent feeding processes. However, the specific molecule that functions in the
development and maintenance of a blood pool is yet to be identified. Recently, we have reported on longistatin, a 17.8-kDa
protein with two functional EF-hand Ca
++-binding domains, from the salivary glands of the disease vector, Haemaphysalis
longicornis, that has been shown to be linked to blood-feeding processes. Here, we show that longistatin plays vital roles in
the formation of a blood pool and in the acquisition of blood-meals. Data clearly revealed that post-transcriptional silencing
of the longistatin-specific gene disrupted ticks’ unique ability to create a blood pool, and they consequently failed to feed
and replete on blood-meals from hosts. Longistatin completely hydrolyzed a, b and c chains of fibrinogen and delayed
fibrin clot formation. Longistatin was able to bind with fibrin meshwork, and activated fibrin clot-bound plasminogen into
its active form plasmin, as comparable to that of tissue-type plasminogen activator (t-PA), and induced lysis of fibrin clot and
platelet-rich thrombi. Plasminogen activation potentiality of longistatin was increased up to 4 times by soluble fibrin. Taken
together, our results suggest that longistatin may exert potent functions both as a plasminogen activator and as an
anticoagulant in the complex scenario of blood pool formation; the latter is critical to the feeding success and survival of
ixodid ticks.
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Introduction
Blood coagulation is a very complex but well-synchronized
biochemical process by which blood forms a clot and the damaged
blood vessel is sealed by a platelet-rich fibrin plug leading to
hemostasis. Any damage to the vascular beds due to laceration of
tissues exposes tissue factor from the endothelium to the
circulating blood, which initiates coagulation cascades. Once
coagulation is initiated, the process leads to the generation of
thrombin, which converts fibrinogen to fibrin, the building block
of a hemostatic plug [1–5]. In contrast, fibrinolysis is an enzymatic
process wherein a fibrin clot is dissolved. Normally, in the body,
both coagulation and fibrinolytic processes are precisely regulated
by the measured participation of zymogens, activators, inhibitors,
cofactors and receptors. Plasmin is the major fibrinolytic enzyme
and is derived from the limited proteolytic cleavage of plasmin-
ogen, the circulating plasma zymogen, by its physiological
activators such as tissue-type plasminogen activator (t-PA) and
urokinase-type plasminogen activator (u-PA) [6–9]. Homeostasis
in blood fluidity is not only vital for humans but also for
hematophagous animals, which have to counteract their hosts’
hemostatic mechanisms and/or facilitate the fibrinolytic process to
keep the blood in a fluid state during acquisition and digestion of
blood-meals. Therefore, it is believed that blood sucking-animals
require an extensive spectrum of anticoagulant and/or fibrinolytic
mechanisms to maximize their feeding as part of their diverse
survival strategies. Thus, hematophagous animals are thought to
possess anticoagulant and/or fibrinolytic proteins that have been
acquired during their evolution [1,10,11].
The ixodid ticks (Arthropoda: Ixodidae), popularly known as
hard ticks, are notorious ectoparasites and live entirely on
nutrients derived from host’s blood protein, hemoglobin. Blood-
feeding is an essential biologic phenomenon for the survival of
hard ticks [12–14]. These ectoparasites firmly attach to hosts using
their deeply penetrating mouthparts on hosts’ skin and cause
dermatitis and severe anemia. In addition to the direct severe
adverse effects on health and productivity, ticks serve as a unique
vector of various deadly diseases, such as lyme disease, tick-borne
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and anaplasmosis during hematophagy. Ticks are only second to
mosquitoes as vectors of diseases of humans and animals [15–20].
Unlike rapidly feeding hematophagous insects that suck blood
directly from the blood vessels within a couple of seconds, the hard
ticks feed on blood-meals for a long time (5210 days or more),
making a large blood pool beneath the host’s skin. Although size of
the blood pool produced by different species of ticks varies but it is
an essential feature in the feeding mechanism of ticks [13,21].
Blood pools contain copious unclotted blood and exudates,
especially in the rapid phase of feeding [1,21]. It is of current
interest to look at the molecular scenario inside the blood pool that
maintains a large volume of unclotted blood underneath the skin.
Prior studies suggest that ixodid ticks, the smart pharmacologists,
produce a vast array of pharmacologically active bio-molecules
that are injected into the feeding lesions during persistent blood-
feeding processes, and play crucial modulatory roles in their
feeding success, especially to keep the blood in a fluid state in the
blood pool and within the gut as well [22–26]. However, the
precise molecular mechanism(s) that prevents blood coagulation
and initiates fibrinolysis in the blood pool to facilitate successful
acquisition of blood-meals is still unclear. Previously, we have
shown that longistatin, an ixodid tick salivary gland-derived
bioactive molecule, is functionally linked to the blood-feeding
processes. The molecule was shown to be secreted into the blood
pool created by ticks while they attach on a robust mammalian
host and suck blood to engorge [27].
Here, we demonstrate that longistatin-specific gene-knockdown
ixodid ticks such as Haemaphysalis longicornis completely lost their
unique ability to create a blood pool and consequently were
unable to feed and engorge on blood-meals as verified by RNA
interference (RNAi) tool. Furthermore, we describe that longistatin
binds with fibrin and specifically catalyzes the activation of
plasminogen into plasmin and hydrolyzes fibrinogen in vitro; the
latter is known to be a major component of cross-linked fibrin
polymer. To the best of our knowledge, longistatin is the first
plasminogen activator, isolated and characterized from hema-
tophagous arthropods.
Results
Injection of dslongistatin inhibits the transcription and
translation of endogenous longistatin
Total RNA isolated from salivary glands of ticks of different
feeding phases of both control and treated groups was analyzed by
reverse transcription-PCR (RT-PCR) and quantitative RT-PCR
(qRT-PCR) to demonstrate the effect of RNAi on the expression
of longistatin-specific mRNA. The RT-PCR data revealed that
injection of dslongistatin completely abolished the detectable
mRNA expression corresponding to the longistatin-specific gene
in ticks (Figure 1A). Our qRT-PCR data also supported this
finding. However, in the RNAi-treated group, longistatin-specific
transcript, although very low compared with that of control, was
detected in ticks at 24, 48 and 72 h of feeding only by qRT-PCR
(Figure 1B). This variation in the detection of longistatin-specific
mRNA by RT-PCR and qRT-PCR may be due to the sensitivity
of the techniques. Furthermore, the presence of a detectable level
of mRNA in the RNAi-treated group of ticks might be due to
individual variations in the tick population. Here, we used pools of
salivary-gland extracts, isolated from three randomly selected ticks
in each feeding phase; thus, it is quite reasonable that the effects of
RNAi were not exactly uniform in each and every microinjected
tick. Longistatin-specific gene expression was detected in its
normal pattern [27] in ticks injected with dsRNA complementary
to the gene encoding maltose-binding protein in Escherichia coli
(dsmalE) (Figures 1A and B), indicating that injection of dslongistatin
caused disruption of longistatin-specific mRNA transcription. For
in situ detection of the effect of RNAi on the translation of
endogenous longistatin, salivary glands were collected from
partially fed (96 h) ticks of both treated and control groups and
were subjected to immunofluorescence staining using mouse anti-
longistatin sera. Longistatin-specific reactions were almost absent
in dslongistatin-injected ticks whereas binding of mouse anti-
longistatin antibody was detected in the salivary glands of
dsmalE-injected ticks (Figure 1C), suggesting that injection of
dslongistatin efficiently silenced longistatin-specific mRNA expres-
sion and subsequent translation of longistatin. To further validate
our results regarding in vivo longistatin gene silencing, we conducted
Western blot analysis using salivary gland extracts collected from
both treated and control ticks. Longistatin-specific bands were
detected only in the salivary gland extracts of dsmalE-injected ticks
and longistatin was upregulated with the feeding process of ticks
(Figure 1D). These findings further reinforced the evidence of
longistatin-specific gene silencing by dslongistatin injection in ticks.
RNAi-treated ticks failed to develop a blood pool and
were unable to feed blood-meals from hosts
All ticks microinjected with dsRNA were active and healthy
during the incubation period. After placement on rabbits’ ears, all
ticks of both treated and control groups actively attached.
However, in the dslongistatin-injected group, 3 (2.5%) ticks were
found dead at 72 h of attachment. All ticks in the dsmalE-injected
group reached to repletion and detached by day 6 post-
attachment. Notably, dslongistatin injection was shown to hamper
the feeding of ticks. These ticks were poorly fed and most of them
failed to engorge (Figure 2A). Only two ticks (1.66%) dropped off
the host following engorgement in the RNAi group. The mean
body weight of the ticks collected after 6 days of feeding was
significantly (P,0.01) lower in the RNAi-treated group
(53.53650.38 mg) than that of the control group (253.436
57.91 mg) (Figure 2B). Visible phenotypic changes were also
obvious among the ticks of the treated and control groups. Ticks of
the treated group, despite 6 days of feeding, were very small with a
Author Summary
Ixodid ticks are serious blood-sucking ectoparasites that
are essentially dependent on blood-meals from hosts for
survival. The feeding mechanism of hard ticks, however, is
very complex and is quite different from that of blood-
sucking insects that suck blood rapidly and directly from
blood vessels. Hard ticks suck blood for quite a long period
(5210 days or more) by making a large blood pool
beneath the skin. Despite the fact that mammalian hosts
are armored with strong blood clotting machineries, ticks
manage to keep the blood in a fluid state and to maintain
a blood pool until a full blood-meal is secured. However,
very little is known about the anti-hemostatic mechanisms
by which ticks cleverly manipulate the host’s blood
clotting cascade and make blood-meals available. Here,
we show that longistatin, a salivary gland protein
identified from the tick Haemaphysalis longicornis, can
efficiently manipulate the host’s blood clotting machiner-
ies, such as fibrinogen, fibrin and plasminogen, and can
help prevent cascade of blood clotting. In conclusion,
longistatin plays a crucial role in the blood-feeding success
of hard ticks and can be a novel therapeutic target against
ticks and tick-borne diseases, including human occlusive
cardiovascular diseases like thrombosis.
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ticks of the control group, which dropped off the host following full
engorgement, were large and glossy in appearance with dorsal
cuticular wrinkling (Figure 2B).
A marked difference between blood pools induced by the ticks
of RNAi-treated and control groups was observed. Large blood
pools were developed at the site of attachment of each tick of the
control group. Grossly, blood pools were large enough with an
estimated mean size of 19.5367.85 mm
2, containing a consid-
erable amount of exudates and blood. The affected area was
cyanotic or dark bluish in color. Blood vessels in the vicinity of
the blood pool were congested and distended. The surrounding
area of the blood pool was markedly hyperemic. On the contrary,
most of the ticks of the RNAi-treated group failed to establish a
feeding lesion. Importantly, significantly (p,0.01) smaller blood
pools (4.2566.38 mm
2) were detected in few individual ticks.
Also, no prominent gross pathological changes were detected at
the site of attachment of RNAi-treated ticks (Figures 2C and D).
To study the histological features, we stained the thin tissue
sections of the blood pool areas with Elastica-van Gieson stain
(EVGS) where hemorrhagic areas exhibited a bright golden
yellow color, indicating that blood pools, developed at the site of
attachment of the dsmalE-injected ticks, were flooded with RBC.
Notably, hemorrhagic changes were not detected at the biting
areas of ticks of the RNAi-treated group (Figure 2E), suggesting
that the longistatin gene plays vital roles in the formation and
maintenance of a blood pool as preceded by marked hemorrhage
into tick-feeding lesions. In addition, an attempt was made to
detect endogenous longistatin in the feeding lesions produced by
the ticks of both groups using mouse anti-longistatin sera.
Longistatin-specific bright green fluorescence was detected at
the well-developed blood pool areas produced by the dsmalE-
injected ticks but no such reaction was detected at the feeding
lesions induced by dslongistatin-injected ticks (Figure 2E), which
further suggests a possible role of longistatin in the blood pool
formation.
Longistatin degrades fibrinogen and delays fibrin clot
formation
To judge the anticoagulant function, longistatin was reacted
with several coagulation factors (viz., thrombin, factors VIIa and
Xa) using different approaches but none of them was affected by
longistatin. Interestingly, longistatin was found to delay fibrin clot
formation, degrade fibrinogen and efficiently activate plasminogen
to its active form, plasmin. To evaluate the anticoagulation
potential of longistatin, fibrinogen (7.5 mM) was pre-incubated in
the absence or presence of longistatin (0.1, 0.2, 0.4, 0.8 and
1.6 mM) or plasmin (1.6 mM) and then thrombin (0.10 NIH unit/
ml) was added as described in Materials and Methods. Longistatin
significantly (p,0.01) interrupted the normal fibrin clot formation
in a concentration-dependent manner. In the absence of long-
istatin, fibrin clot was formed within 15 min, but in the presence of
longistatin (1.6 mM) or plasmin (1.6 mM), no visible clot was
developed within this time (Figure 3A). Longistatin was shown to
Figure 1. Post-transcriptional silencing of longistatin-specific gene in adult ticks by injecting dsRNA. (A) Semiquantitative RT-PCR
analysis. One microgram of longistatin dsRNA was injected into the hemolymph of ticks of the RNAi-treated group. Ticks of the control group were
treated with 1 mgo fmalE dsRNA. Actin was used as an internal control. Eng, engorged. (B) Quantitative RT-PCR using total RNA and primers specific
for longistatin as in A. Eng, engorged. (C) In situ detection of longistatin expression in ticks’ salivary glands. Salivary glands from the ticks of control
and RNAi-treated groups. Endogenous longistatin was reacted with mouse anti-longistatin sera (1:100). (D) Effect of gene silencing on longistatin
post-translation by Western blot analysis. Salivary gland extracts were electrophoresed and transferred onto nitrocellulose membrane. Endogenous
longistatin was probed with mouse anti-longistatin (1: 100). Eng, engorged.
doi:10.1371/journal.ppat.1001312.g001
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significantly extended (up to 90 min) at a concentration of 1.6 mM
longistatin (Figure 3B), indicating potent anticoagulant activity of
longistatin. To explore the fibrinogenolytic potential, fibrinogen
was incubated in the absence or presence of longistatin (0.4, 0.8
and 1.6 mM) or plasmin (1.6 mM) and was subjected to SDS–
PAGE analysis. Longistatin potently degraded the a, b and c
chains of fibrinogen in a concentration-dependent manner.
Longistatin completely hydrolyzed all three chains of fibrinogen
at 1.6 mM concentration, as it was done by 1.6 mM plasmin
(Figure 3C), implying that longistatin is an efficient fibrinogenoly-
tic protease of ixodid ticks.
Figure 2. Effects of post-transcriptional silencing of longistatin gene on blood pool formation and blood feeding. (A) Impact of
longistatin-specific mRNA silencing on blood-meal feeding from hosts. Adult ticks were injected with longistatin dsRNA or malE dsRNA (1 mg/tick) and
were allowed to feed on a tick-naı ¨ve rabbit. RNAi-treated ticks failed to replete. (B) Postengorgement weight was significantly (p,0.01) lower in the
RNAi-treated group than that of the control group. Dotted lines indicate mean6SD of body weight of ticks. (C) Effects of post-transcriptional
silencing of longistatin gene on blood pool formation. RNAi was performed and ticks were fed in the same manner as in A. RNAi-treated ticks failed to
establish a prominent blood pool. Arrows indicate site of tick attachment. (D) Blood pools were significantly (p,0.01) smaller in the RNAi-treated
group. (E) Histopathological changes were studied using EVGS. Longistatin was detected in the feeding lesions of ticks on the host’s tissues using
mouse anti-longistatin sera (1:100).
doi:10.1371/journal.ppat.1001312.g002
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soluble fibrin
Initially, we determined the plasminogen activation potential of
longistatin by measuring the amidolytic activity of activated
plasminogen on the plasmin-specific fluorogenic substrate. Data
revealed that the initial rate of plasminogen activation was
proportional to the concentration of longistatin. Hydrolysis of
plasmin-specific substrate sharply increased with the increase of
concentration of longistatin. However, longistatin alone, even at a
higher concentration (640 nM), was not able to induce hydrolysis
of plasmin-specific fluorogenic synthetic substrate (Figure 4A),
indicating that longistatin activated plasminogen into its active
form, plasmin, which hydrolyzed the synthetic substrate releasing
MCA. Most interestingly, plasminogen activation potential of
longistatin was significantly increased in the presence of soluble
fibrin and induced robust amidolytic activity. Addition of fibrin
cyanogen bromide (CNBr) fragments (4 mg) to the assay mixture
caused an increase of plasminogen activation rate up to 4 times
higher than that in the absence of fibrin CNBr fragments
(Figure 4B). CNBr fragments of fibrin, the soluble fibrin, is
usually regarded as a t-PA stimulator and increases the rate of
plasminogen activation about 5 times [28,29]. Plasminogen was
sparingly affected by longistatin in the absence of soluble fibrin
(Figure 4B), indicating the extraordinary specificity of longistatin
towards fibrin-bound plasminogen rather than free circulating
plasminogen.
Longistatin is able to lyse fibrin clot by activating
plasminogen
Although plasmin has enzymatic activity towards a broad
spectrum of substrates, but the fibrin clot is considered as its main
native substrate [30]. To further evaluate the plasminogen
activation efficiency of longistatin, fibrin polymer was incubated
with plasminogen–longistatin/-t-PA mixture or with buffer only at
25uC for 24 h. Data revealed that, in the presence of either
longistatin or t-PA, plasminogen was able to induce lysis of fibrin
clot. Visual observation and spectrometric analysis at 450 nm
(OD450) revealed that the fibrinolytic potential of plasminogen, in
Figure 3. Anti-coagulation and fibrinogenolytic activity of longistatin. (A) Effects of longistatin on the formation of fibrin clot. Fibrinogen
(7.5 mM) was pre-incubated in a buffer in the absence or presence of longistatin (0.1, 0.2, 0.4, 0.8 and 1.6 mM) or plasmin (1.6 mM) and then thrombin
was added (0.10 NIH unit/ml) as described in Materials and Methods. Clot formation was detected visually and also by determining changes in
turbidity at OD450 using a spectrophotometer after 15 min. (B) Longistatin (1.6 mM) delayed fibrin clot formation up to 90 min. Fibrinogen was
incubated in the absence or presence of longistatin (1.6 mM) following the same procedures as mentioned in A and then thrombin was added. OD450
was measured at 15 min intervals. (C) Fibrinogenolytic effect of longistatin. Fibrinogen (7.5 mM) was incubated in the absence or presence of
longistatin (0.4, 0.8 and 1.6 mM) or plasmin (1.6 mM). Samples were collected at the indicated time period and were subjected to 12.5% SDS–PAGE
analysis under reducing conditions. A gradual degradation of the a, b and c chains of fibrinogen was detectable with the concomitant deposition of
degraded products. Asterisks (
*) indicate that the difference compared with the negative control group (buffer only) is significant as determined by
Student’s t-test with unequal variance (
*p,0.05,
**p,0.01).
doi:10.1371/journal.ppat.1001312.g003
Longistatin Is Key to the Feeding in Ticks
PLoS Pathogens | www.plospathogens.org 5 March 2011 | Volume 7 | Issue 3 | e1001312the presence of longistatin, was directly proportional to the
concentration of the recombinant protein used. These results
firmly suggest that longistatin activates plasminogen to an active
plasmin in a concentration-dependent manner, which in turn lyses
the visible fibrin clot. Longistatin caused complete lysis of fibrin
clot in the nanomolar range (Figures 5A and B). SDS–PAGE
analysis showed that longistatin efficiently cleaved plasminogen
into its heavy and light chains. These results are comparable to
Figure 4. Plasminogen activation by longistatin. (A) Longistatin (40, 80, 160, 320 and 640 nM) was incubated without or with plasminogen
(0.24 units) adding fibrin CNBr fragments (4 mg) in a total volume of 200 ml of buffer (50 mM Tris–HCl, pH 7.5; 100 mM NaCl and 5 mM CaCl2)a t2 5 uC
for 2 h. Then, plasmin-specific fluorogenic substrate (100 mM, final concentration) was added and substrate hydrolysis was monitored by measuring
excitation and emission wavelengths of 360 nm and 460 nm, respectively, at 15 min intervals. Inset, initial rate of plasminogen activation at different
concentrations of longistatin. (B) Effects of fibrin CNBr fragments on the activation of plasminogen by longistatin. Plasminogen (0.24 units) was
incubated with longistatin (640 nM) in the absence or presence of fibrin CNBr fragments (0.25, 1 and 4 mg) as described in Materials and Methods. All
assays were performed in triplicate.
doi:10.1371/journal.ppat.1001312.g004
Figure 5. Longistatin induced fibrinolysis by activating plasminogen. (A) Fibrin clot was formed by incubating fibrinogen (7.5 mM) and
thrombin (0.10 NIH unit/ml) and was incubated in the presence of plasminogen-t-PA/-longistatin (40, 80, 160, 320 and 640 nM) mixture or buffer only
at 25uC for 24 h. Clot lysis was measured at OD450. Plasminogen induced complete lysis of fibrin clot in the presence of 640 nM longistatin or 154 nM
t-PA. (B) Time-dependent activation of plasminogen by longistatin with concomitant lysis of fibrin clot. (C) Cleavage of plasminogen into the heavy
and light chains. Digested product of fibrin clot was electrophoresed by 12.5% SDS–PAGE. Asterisks (
*) indicate that the difference compared with the
negative control group (buffer only) is significant as determined by Student’s t-test with unequal variance (
*p,0.05,
**p,0.01,
***p,0.001).
doi:10.1371/journal.ppat.1001312.g005
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(Figure 5C). Here, we also observed that longistatin activated a
sufficient amount of plasminogen only in the presence of fibrin clot
and induced profound fibrinolysis (data not shown).
Longistatin binds with fibrin
To explore the fibrin-binding capability of longistatin, we
conducted fibrin-binding assays. Longistatin-specific green fluo-
rescence was detected in the fibrin meshwork when purified
recombinant longistatin was incorporated with fibrin and reacted
with anti-longistatin sera. However, longistatin-specific fluorescent
reaction was completely absent in the absence of longistatin in the
reaction mixture or when longistatin-impregnated fibrin mesh-
work was treated with pre-immune sera (1:100), indicating that
longistatin is able to bind with fibrin clot. To compare the fibrin
binding of longistatin, we used t-PA as a positive control because t-
PA is known to bind with fibrin [31]. Here, t-PA-specific
fluorescence was only detected when t-PA added fibrin was
treated with anti-t-PA mouse monoclonal antibody (1:100), but no
such reaction was visible in the presence of pre-immune sera
(normal serum) at the same concentration. To evaluate the
specificity of the fibrin-binding assays, we used u-PA as a negative
control because u-PA does not bind with fibrin [32]. u-PA-specific
reaction was not detected in the fibrin meshwork even in the
presence of a relatively high concentration (1:20) of anti-u-PA
antibody (Figure 6A). By using SDS2PAGE analysis, we also
observed that the concentration of residual longistatin was
markedly reduced after fibrin clot formation (Figure 6B), which
reinforced the assertion that longistatin was bound with the fibrin
clot. Furthermore, we determined the concentration of long-
istatin/t-PA in the supernatant obtained from the fibrin-binding
assay mixer and data revealed that the percentage of binding of
longistatin/t-PA with fibrin meshwork was directly proportional to
the amount of fibrin. Longistatin binding was 97.93%61.68%
when 60 mM fibrinogen was used to produce fibrin clot and,
under the same conditions, binding of t-PA was 90.6%61.2%.
Specificity of the binding was evidenced by the absence of u-PA
binding (Figure 6C). To evaluate the fibrin-binding potentials of
longistatin, we determined the fibrin-binding parameters of
longistatin and compared them with those of t-PA. Longistatin
was shown to bind with fibrin with the estimated Kd,B max and
molar binding ratio (MBR) of 145.563.3 nmol/L, 3.160.6 mmol/
L and 42.367.4, whereas those of t-PA were 159.267.4 nmol/L,
1.460.4 mmol/L and 19.364.7, respectively (Table 1), suggesting
that longistatin potently binds with fibrin. Fibrin binding is an
essential feature for the plasminogen activators that specifically
activate fibrin clot-bound plasminogen. For example, t-PA is a
very weak activator of plasminogen in the absence of fibrin. The
affinity between t-PA and plasminogen is significantly increased in
the presence of fibrin of blood clot [6,33]. Fibrin binding was also
assumed as critical in the activation process of plasminogen by
longistatin.
Longistatin activates plasminogen present in plasma
milieu and induces thrombolysis
To demonstrate the thrombolytic capability of longistatin, we
treated freshly prepared platelet-rich thrombi kept in fresh plasma.
Longistatin was able to cause lysis of platelet-rich thrombi in the
presence of fresh plasma in a concentration-dependent manner
and efficiently lysed thrombi at 640 nM concentration (Figure 7A).
Longistatin induced more than 50% lysis of thrombi within 2 h at
640 nM concentration (data not shown). In the same experimental
setup, longistatin (640 nM) and t-PA (154 nm) induced 93.62%6
2.33% and 98.78%62.11% lysis of thrombi, respectively, by 12 h
(Figure 7B). Moreover, like t-PA, longistatin efficiently digested
fibrin clot produced from purified, commercially available
fibrinogen and thrombin in the presence of plasma (data not
shown). Taken together, our results suggest that longistatin is
capable of causing thrombolysis and subsequent recanalization of
occluded thrombosed vascular tree by activating the physiological
level of plasminogen into plasmin.
Functional implications of longistatin in blood
coagulation and fibrinolysis cascades
We hypothesized that ixodid ticks synthesize longistatin and
possibly other functionally related bioactive molecules to efficiently
counteract host’s hemostatic ability and/or to activate its own
fibrinolytic machinery to create blood pools for the acquisition of
blood-meals and engorgement. Our in vivo and in vitro data strongly
support this hypothesis and that longistatin exerts its multifunc-
tional roles both in coagulation cascades and in fibrinolytic
pathways. In this study, we proposed a longistatin-induced anti-
coagulation and fibrinolytic mechanism that works persistently
against host’s hemostatic pathways until ticks ensure full blood-
meals (Figure 8).
Discussion
Previous literatures on the feeding behavior and physiology of
hematophagous ixodid ticks suggest that acquisition of blood-
meals from mammalian hosts is modulated by a vast array of
pharmacologically active bio-molecules secreted from the salivary
glands of these amazing tiny arthropods. Ticks’ saliva is thought to
efficiently manipulate the hosts’ strong defense mechanisms, such
as hemostasis, inflammatory reactions and immune responses that
are induced against the tick during hematophagy [1,26,34–37]. In
the present study, we provide evidence that longistatin, a salivary
gland protein with two functional EF-hand Ca
++-binding domains
isolated from the ixodid tick, H. longicornis, binds with fibrin and
specifically activates plasminogen to its active form, plasmin. We
also demonstrate that longistatin degrades fibrinogen and is able to
delay fibrin clot formation; thus, longistatin appears to be essential
to keep the blood in a fluid state in the blood pool, which enables
ticks to feed and replete on blood-meals from hosts.
Our in vivo gene silencing study revealed that longistatin-specific
gene-knockdown ticks were unable to produce a blood pool and
consequently failed to replete. These findings prompted us to
unveil the underlying complex mechanism(s) by which longistatin
exerts its modulatory roles in blood pool formation and
maintenance, which is an essential pre-requisite to ticks for
successful feeding and engorgement. Anticoagulation of host’s
blood is a crucial step for the development and maintenance of a
blood pool. To verify this, we have conducted several anticoag-
ulation and fibrinolysis assays. Interestingly, we have shown that
longistatin significantly extends the time of fibrin clot formation up
to 90 min when fibrinogen is treated with longistatin compared
with untreated fibrinogen (control), which takes only 15 min to
complete fibrin clot formation. Data on fibrinogenolytic assays also
support this observation that longistatin is capable of degrading
the a, b and c chains of fibrinogen in a concentration-dependent
manner and completely hydrolyzes these three bands. Therefore,
it may be assumed that the delay in the fibrin clot formation
during in vitro anticoagulation assays in the presence of longistatin
is due to the gradual degradation of coagulable proteins in the
reaction mixture. Fibrinogenolytic activity has also been reported
in tick metalloprotease isolated from Ixodes scapularis [38] and in
several proteases identified from snake venoms [39] and spider
toxins [40]. Fibrinogen is the key component for the formation of
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PLoS Pathogens | www.plospathogens.org 7 March 2011 | Volume 7 | Issue 3 | e1001312Figure 6. Binding of longistatin with fibrin clot. (A) Detection of longistatin bound on fibrin meshwork. Fibrinogen at different concentrations
(3.75, 7.5, 15, 30 and 60 mM; final concentration) was mixed in the absence or presence of longistatin (10 mg) or an equal amount of t-PA or u-PA in a
buffer (50 mM Tris–HCl, pH 7.5; 100 mM NaCl and 5 mM CaCl2) and thrombin (0.10 NIH unit/ml) was added immediately and was incubated at 25uC
for 1 h. The clot was treated with anti-longistatin (1:100), anti-t-PA (1:100), anti-u-PA (1:20) or pre-immune sera (1:100). Bound antibodies were
detected using green fluorescent-labeled secondary antibody (Alexa Flour 488 goat anti-mouse IgG). (B) Supernatant was analyzed by 12.5% SDS–
PAGE under reducing conditions. (C) The target protein was extracted from the supernatant and its concentration was determined using micro-BCA
reagent as described in Materials and Methods. The results are expressed as percentage of longistatin/t-PA/u-PA bound to the fibrin clot. Data
represent mean 6 SD, n=3.
doi:10.1371/journal.ppat.1001312.g006
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vessels, platelets are exposed to the subendothelial collagen and
become activated and aggregated around the injuries. Then, fibrin
strands, derived from cleavage of fibrinogen, intertwine about the
aggregated platelets giving rigidity and stability of the initial and
preliminary platelet plugs. Finally, activated factor XIII forms
covalent bonds that crosslink the fibrin polymers and thus the
injured blood vessels are sealed by an extra strengthened, stable
fibrin clot leading to hemostasis [1,41,42]. Therefore, it may be
predicted that fibrinogenase activity of longistatin hampers
hemostasis and may facilitate hemorrhage into the blood pools
from which ticks persistently feed blood-meals.
We have shown that longistatin specifically activated plasmin-
ogen in the presence of fibrin clot and cleaved it into plasmin,
heavy chain (a) and light chain (b). Although plasminogen is
unable to cleave fibrin clot but it has a strong affinity for fibrin.
Plasminogen has a secondary structure known as a kringle domain,
which anchors plasminogen specifically to the carboxy-terminal
arginine and lysine residues of the fibrin; thus, plasminogen
becomes more concentrated on the surface of the clot, whenever
and wherever it develops. As soon as plasminogen is converted
into plasmin by its activators, it functions like a serine protease.
Fibrin acts as a cofactor in the enzymatic activation reactions
when plasminogen is activated by the fibrin-selective agents, like t-
PA and its derivatives or staphylokinase and its derivatives.
Through a highly orchestrated biochemical process, plasmin
initially creates nicks on the fibrin and further digestion leads to
the complete dissolution of fibrin meshwork into soluble fibrin
degradation products [6,32,43]. Our results clearly demonstrate
that longistatin contributes to this well-coordinated fibrinolytic
pathway by activating plasminogen into plasmin. Plasmino-
gen activators have been purified from the venomous snake,
Trimeresurus stejnegeri [44] and from the saliva of common vampire
bat, Desmodus rotundus [10,45]. In vampire bats, plasminogen
activator is thought to be a key enzyme that plays a crucial role in
the maintenance of the flow of blood during the feeding process
[46] and snake-venom plasminogen activator is associated with the
pathogenesis of envenomation rendering the blood incoagulable
[44]. Maintenance of hosts’ blood fluidity at the site of biting is
also very critical for the development of blood pool and subsequent
blood feeding, and eventually for the survival of ixodid ticks. From
the available evidence, here we assume that fibrin-specific,
plasminogen-activation-dependent thrombolytic potentiality of
longistatin plays significant functional roles in the pathobiology
of vector ticks through the formation of feeding lesion and by the
maintenance of its homeostasis throughout the entire period of
blood feeding.
In conclusion, longistatin, a salivary-gland protein of ixodid ticks
with multitarget potential, shows high specificity for fibrin clot-
bound plasminogen, and degrades fibrinogen. These findings
indicate that longistatin plays significant roles in the formation and
maintenance of blood pools leading to the successful acquisition of
blood-meals and may be critical for the survival of ixodid ticks.
Furthermore, our data suggest that longistatin may serve as a
novel therapeutic target against ticks and tick-borne diseases,
including human diseases such as thrombosis or other occlusive
cardiovascular accidents.
Materials and Methods
Ticks and animals
We propagated parthenogenetic Okayama strains of H. long-
icornis at the Laboratory of Parasitic Diseases, National Institute of
Animal Health (NIAH), Tsukuba, Japan, by feeding on the ear of
tick-naı ¨ve, specific-pathogen-free Japanese White rabbits accord-
ing to methods described previously [27]. Ticks were collected
after detachment following full engorgement or at the indicated
period of feeding. After collection, ticks were weighed and
phenotypic differences between the ticks of RNAi and control
groups were recorded. This study was carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Table 1. Comparison of fibrin-binding parameters of
longistatin with those of t-PA.
Protein Kd (nmol/L) Bmax (mmol/L) MBR
a
Longistatin 145.563.3 3.160.6 42.367.4
t-PA 159.267.4 1.460.4 19.364.7
p,0.05 p,0.01 p,0.01
aExpressed as moles of longistatin/t-PA per mole of fibrin. Determined at
maximum binding.
doi:10.1371/journal.ppat.1001312.t001
Figure 7. Lysis of platelet-rich thrombi by longistatin in dog plasma. (A) Longistatin hydrolyzes platelet-rich thrombi ex vivo in dog plasma.
Platelet-rich clot was produced by incubating 0.2 ml of dog blood and the thrombi were treated with longistatin at various concentrations in 0.5 ml
of dog plasma at 37uC for 12 h and weighed at the indicated period. (B) Comparison of thrombolytic activity of longistatin with that of t-PA. Thrombi
were treated with longistatin (640 nM)/t-PA (154 nM) under the same ex vivo experimental conditions.
doi:10.1371/journal.ppat.1001312.g007
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the Ethics of Animal Experiments of the NIAH (Permit Number:
09-017, 09-018, 10-008, 10-010). All surgeries were performed
under sodium pentobarbital anesthesia, and all efforts were made
to minimize the animals’ suffering.
Reagents
Green fluorescent-labeled secondary antibody (Alexa Flour 488
goat anti-mouse IgG (H+L)) was purchased from Invitrogen and
alkaline phosphatase-conjugated goat anti-mouse IgG (H+L) was
from ZYMED. Nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl
phosphate (BCIP/NBT) and T7 RNA polymerase were from
Promega. Purified human plasmin, bovine thrombin and fibrinogen
were obtained from Sigma. Purified human plasminogen, t-PA and
anti-t-PA (Ab-1) mouse monoclonal antibody (GMA-043) were
purchased fromCalbiochem.Humanu-PAwasfromCosmoBioCo.
LTD and polyclonal antibody to u-PA was from Acris Antibodies
GmbH. Fibrin CNBr fragment was obtained from Technoclone and
Boc-Glu-Lys-Lys-MCA from Peptide Institute. Total RNA extrac-
tion kit and DNA gel extraction kit were purchased from QIAGEN.
RNA interference
We performed RNAi using dsRNA following a protocol
described previously [47]. The sequence coding longistatin was
cloned into pBluescript II SK
+ vector in XhoI and EcoRI restriction
sites following a protocol described previously [27]. The dsRNA
complementary to the E. coli malE gene that encodes maltose-
binding protein was used as a negative control. cDNA corre-
sponding to malE mRNA was synthesized and was cloned into
pBluescript II SK
+ plasmid using the primers 59-CCGCTCG-
AGCGGTTATGAAAATAAAAACAGGTGCA-39 and 59-GAA-
TTCGCTTGTCCTGGAACGCTTTGTC-39. The inserted se-
quences of longistatin and malE were amplified by PCR using
primers T7 (59-GTAATACGACTCACTATAGGGC-39) and
CMO422 (59-GCGTAATACGACTCACTATAGGGAACAAA-
AGCTGGAGCT-39) to attach to T7 promoter recognition sites at
either end. The PCR products were purified using gel extraction
kit (QIAGEN). dsRNA complementary to the respective DNA
inserts was synthesized by in vitro transcription using T7 RNA
polymerase (Promega). One microgram of longistatin dsRNA
(dslongistatin, treated group) or malE dsRNA (dsmalE, control group)
was injected into each tick through the 4
th coxa. Ticks were
observed in a humified incubator for 24 h at 25uC prior to
attaching them on the host for feeding. A total of 120 ticks, each of
60 in RNAi and control groups, were attached on the ear of tick-
naı ¨ve rabbits. Ticks were collected at 24, 48, 72 and 96 h of
feeding or after repletion. All ticks collected after they had dropped
off the host following full engorgement were weighed individually
using a digital balance (Sartorius).
Semiquantitative RT-PCR and qRT-PCR
Salivary glands from adult ticks of both control and RNAi
groups at different feeding periods (24, 48, 72, 96 h and engorged)
were collected as described previously [27]. Shortly after collec-
Figure 8. A schematic diagram showing roles of longistatin in blood coagulation and fibrinolysis events. In the initial phase, the tick
bites and lacerates tissues at the site of attachment and damages vascular beds, which results in hemorrhage leading to the development of a blood
pool. Longistatin is synthesized in and secreted from the salivary glands and injected into the blood pool during feeding process [27]. Longistatin
degrades fibrinogen and activates plasminogen to its active form, plasmin. HMWK, high-molecular-weight kininogen; PKK, prekallikrein; TF, tissue
factor. Yellow arrows, contact activation (intrinsic) pathway; olive-green arrows, tissue factor (extrinsic) pathway; green arrows, common pathway of
coagulation cascade and white arrows, fibrinolytic pathway. Figure adapted from ref. [1,6,32].
doi:10.1371/journal.ppat.1001312.g008
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Stabilization Reagent (QIAGEN). Total RNA was isolated using
an RNeasy Mini Kit (QIAGEN) according to the manufacturer’s
protocol and 500 ng of total RNA was used for reverse
transcription before PCR. Single-stranded cDNA was prepared
using Takara RNA PCR Kit (AMV) Ver.3.0 (Takara) following
the manufacturer’s instructions. A series of PCRs were carried out
using 500 ng of cDNA from each sample and longistatin-specific
oligonucleotides (59GCTATCTCGGCTCCTGTGTC 39 and
59ATCTTCGCCAGGTCCTTCTT 39) or oligonucleotides spe-
cific for a control cDNA encoding b-actin in a final volume of
20 ml. The PCR product was subjected to electrophoresis in 1%
agarose gel. The qRT-PCR was performed in a LightCycler 1.5
instrument (Roche Instrument Centre AG) using LightCycler
FastStart DNA Master SYBR Green I (Roche Diagnostics)
following a procedure described previously [48]. The reaction
mixture of 20 ml contained 4 mM MgCl2, 0.5 mM of each primer
(forward and reverse as described above) and 2 ml (250 ng/ml) of
the single-stranded DNA template. The data obtained were
analyzed using LightCycler Software Version 3.5.
Recombinant longistatin and polyclonal antibody
production
Recombinant longistatin was produced, purified, dialyzed and
its concentration was determined as previously described [27].
Purified longistatin was kept at –20uC until further use. Polyclonal
antibody was produced in BALB/c mice following a procedure
described elsewhere [27].
Immunofluorescence and histopathology
We collected salivary glands from partially fed (96 h) adult ticks
of both control and RNAi groups as described above. Salivary
glands were placed on slides and were fixed with 4% paraformal-
dehyde. Salivary glands were then permeabilized with 0.1%
tritonX-100 and were treated with mouse anti-longistatin sera
(1:100). Bound antibodies were detected using green fluorescent-
labeled secondary antibody (Alexa Flour 488 goat anti-mouse IgG
(H+L), Invitrogen). Slides were mounted with VECTASHIELD
mounting medium containing 49,6-diamidino-2-phenylindole
(DAPI, Vector Laboratories) and examined under a fluorescent
microscope (Leica). In addition, thin sections were prepared from
tissues collected from the feeding lesions developed on a rabbit’s
ear at the site of attachment of the ticks. Tissue sections were then
subjected to immunofluorescent staining using mouse anti-long-
istatin sera as described previously[27]. Rabbit’s tissues were also
stained with EVGS as described previously [49].
Immunoblot analysis
Equal numbers of adult ticks from both RNAi and control groups
collected at different feeding intervals (24, 48, 72, 96 h and engorged)
were dissected separately in PBS and salivary glands were isolated.
Antigens were prepared as previously described [50]. Equal amounts
of protein (4 mg) were separated by 12.5% SDS2PAGE under
reducing conditions and were transferred onto nitrocellulose mem-
brane. The membrane was treated with mouse anti-longistatin sera
( 1 : 1 0 0 )o v e r n i g h ta t4 uC.Bound antibodies were probed with alkaline
phosphatase-conjugated goat anti-mouse IgG (H+L) (ZYMED). The
membranes were developed with nitroblue tetrazolium/5-bromo-4-
chloro-3-indolyl phosphate (BCIP/NBT, Promega).
Anticoagulation and fibrinogenolytic assays
Fibrinogen (7.5 mM) was pre-incubated in a total volume of
397 ml of buffer containing 25 mM Hepes (pH 7.2) and 25 mM
NaCl in the absence or presence of longistatin (0.1, 0.2, 0.4, 0.8
and 1.6 mM) or plasmin (1.6 mM) at 25uC for 3 h. Fibrin clot
formation was initiated by the addition of 3 ml of thrombin (0.10
NIH unit/ml). Fibrin clot formation was detected visually and also
by determining changes in turbidity at OD450 using a spectro-
photometer (Beckman Coulter) at 15 min intervals. To detect the
fibrinogenolytic activity of longistatin, fibrinogen (7.5 mM) was
incubated in a total volume of 100 ml of buffer (25 mM Hepes,
pH 7.2, and 25 mM NaCl) in the absence or presence of
longistatin (0.4, 0.8 and 1.6 mM) or plasmin (1.6 mM) at 25uC
for 48 h. Aliquots were collected and separated by 12.5% SDS–
PAGE.
Plasminogen activation assays
Longistatin at various concentrations (40, 80, 160, 320 and
640 nM) was incubated in a 96-well cell culture plate without or
with plasminogen (0.24 units) in the absence or presence of fibrin
CNBr fragments (0.25, 1 and 4 mg) in a total volume of 200 mlo f
buffer (50 mM Tris–HCl, pH 7.5; 100 mM NaCl and 5 mM
CaCl2)a t2 5 uC for 2 h. Then, 2 ml (100 mM, final concentration)
of plasmin-specific fluorogenic substrate (Boc-Glu-Lys-Lys-MCA)
was added. Substrate hydrolysis was monitored by measuring
excitation and emission wavelengths of 360 nm and 460 nm,
respectively, at 15 min intervals using a Spectra Fluor fluorometer
(TECAN, Ma ¨nnedorf, Switzerland). All assays were performed in
triplicate and activity of activated plasminogen was expressed in an
arbitrary fluorescent unit per min (AFU/min).
Fibrinolytic assays
Fibrin clot was incubated in the presence or absence of
longistatin. An initial fibrin clot was produced by incubating 10 ml
of fibrinogen (7.5 mM) and 5 ml of thrombin (0.10 NIH unit/ml) in
a total volume of 400 ml of buffer (50 mM Tris–HCl, pH 7.5;
100 mM NaCl and 5 mM CaCl2)a t2 5 uC for 1 h. An equal
volume of plasminogen (2.4 units), t-PA (154 nM) or longistatin at
various concentrations (40, 80, 160, 320 and 640 nM) in a total
volume of 100 ml of buffer, as mentioned above, was added to the
fibrin clot and incubated at 25uC for 24 h. Lysis of fibrin clot was
detected visually and also by measuring changes in turbidity at
OD450 using a spectrophotometer (Beckman Coulter) at different
time intervals (0, 6, 12 and 24 h). Furthermore, to verify the
plasminogen activation potential of longistatin, 20 ml of digested
products of clots corresponding to each concentration were
collected and subjected to 12.5% SDS–PAGE analysis under
reducing conditions.
Fibrin clot binding assays
Fibrin binding assays were conducted with the modifications of
procedures described previously [31]. Briefly, purified fibrinogen
(3.75, 7.5, 15, 30 and 60 mM; final concentration) was mixed in
the absence or presence of longistatin (10 mg) or an equal amount
of t-PA or u-PA in a total volume of 200 ml of buffer (50 mM Tris–
HCl, pH 7.5; 100 mM NaCl and 5 mM CaCl2). Fibrin clot
formation was initiated by adding 3 ml of thrombin (0.10 NIH
unit/ml) immediately and was incubated at 25uC for 1 h. The clot
was centrifuged at 10,000 g for 10 min and supernatant was
collected. The remaining clot was extensively washed in PBS and
treated with anti-longistatin (1:100), anti-t-PA (1:100), anti-u-PA
(1:20) or pre-immune sera (1:100) overnight at 4uC. Bound
antibodies were detected using green fluorescent-labeled second-
ary antibody. Supernatant was analyzed by 12.5% SDS2PAGE
under reducing conditions. The target protein band was excised
and protein was extracted from the gel using negative zinc staining
kit following the manufacturer’s instructions (Bio-Rad). Double
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extracted protein, incubated at 220uC for 1 h and centrifuged at
10,000 g for 30 min. The pellet was air-dried and dissolved with
distilled water. The concentration of the extracted protein was
determined using micro-BCA reagents (Pierce). To determine the
binding parameters, longistatin (2210 mg) or an equal amount of
t-PA was incorporated into the fibrin clot. Residual longistatin/
t-PA was extracted from the supernatant and the concentration of
the relevant protein was determined following the same methods
as mentioned above. Kd,B max and MBR were calculated accord-
ing to the procedures as previously described [51].
Ex vivo thrombolysis assays
Platelet-rich thrombi were produced by incubating 0.2 ml of
fresh dog blood in a 96-well flat-bottom cell culture plate for
15 min. Thrombi were removed and washed gently with normal
saline and weighed using a digital balance (Sartorius). The thrombi
were then treated with t-PA (154 nM) or longistatin at various
concentrations (40, 80, 160, 320 and 640 nM) in a total volume of
0.5 ml of fresh dog plasma at 37uC for 12 h and weighed at 3 h
intervals. Furthermore, fibrin clot was produced by incubating
purified, commercially available fibrinogen (7.5 mM) and throm-
bin (0.10 NIH unit/ml) as mentioned above and was treated with
t-PA (154 nM) or longistatin (640 nM) in fresh dog plasma
following the same experimental procedures and conditions.
Accession numbers of the proteins and the genes used
Plasmin from human plasma (NP_000292), plasminogen
from human plasma (AAN85555), t-PA from human plasma
(NP_000921), u-PA from human plasma (NP_002649.1),
thrombin (as prothrombin) from bovine plasma (NP_776302),
fibrinogen from bovine plasma (a chain, AAI02565; b chain,
NP_001136389 and c chain, AAI02630), longistatin from H.
longicornis (AB519820) and malE from E. coli (ZP_02999303).
Statistical analysis
Data were presented as mean 6 standard error, where
appropriate. Statistical significance was determined using Student’s
t test with unequal variance.
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